Latest News and Press Releases

Lisaftoclax monotherapy demonstrated significant and durable clinical efficacy and a manageable safety profile in patients with heavily pretreated BTK-refractory R/R CLL/SLL, underscoring its utility...

Lakewood Ranch, Dec. 06, 2025 (GLOBE NEWSWIRE) -- JCBC Publishing, LLC, a distinguished name in the literary world, proudly announces the upcoming release of 'That Kind of Girl,' the debut novel by...

Austin, Dec. 06, 2025 (GLOBE NEWSWIRE) -- The Labor Management System Market size was valued at USD 3.69 Billion in 2025E and is expected to reach USD 7.35 Billion by 2033 and grow at a CAGR of...

The case alleges Perrigo hid deep underinvestment and manufacturing issues in its infant formula unit, overstating needed costs and financial results.

Austin, Dec. 06, 2025 (GLOBE NEWSWIRE) -- The System Infrastructure Software Market was valued at USD 161 billion in 2023 and is expected to reach USD 297.18 billion by 2032, growing at a CAGR of...

Media ReleaseCOPENHAGEN, Denmark; December 6, 2025 New two- and three-year EPCORE® NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in...

Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free survival (PFS) of 22.1 months across all doses tested Emerging...

-- Bezuclastinib achieves clear clinical benefit across all symptom domains including significant improvements on 11 individual symptoms plus the most severe symptom at baseline -- ...

Austin, Dec. 06, 2025 (GLOBE NEWSWIRE) -- The In-Memory Database Market size was valued at USD 17.53 Billion in 2025E and is projected to reach USD 59.58 Billion by 2033, growing at a CAGR of 16.54%...

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line1 Data...